Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury

Frontiers in Pharmacology

Pharmacology

Gaoyun Hu¹  Xiaohua Liao²  Yan Zhang²  Liyun Ao²  Qin Dai²  Yue Yu²  Xin Lv²  Lijian Tao³  Zhangzhe Peng³  Yanyun Xie³  Jiajia Li³  Yupeng Jiang⁴  Jie Meng⁵ 

[1] Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China;Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China;Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China;Hunan Key Lab of Organ Fibrosis, Changsha, China;National International Collaborative Research Center for Medical Metabolomics, Xiangya Hospital, Central South University, Changsha, China;Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China;Hunan Key Lab of Organ Fibrosis, Changsha, China;National International Collaborative Research Center for Medical Metabolomics, Xiangya Hospital, Central South University, Changsha, China;Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China;Hunan Key Lab of Organ Fibrosis, Changsha, China;Department of Pulmonary and Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha, China;

关键词: renal ischemia-reperfusion injury;    folic acid;    acute kidney injury;    chronic kidney disease;    mefunidone;   

DOI  :  10.3389/fphar.2023.1188615

 received in 2023-03-17, accepted in 2023-03-27,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Li, Jiang, Dai, Yu, Lv, Zhang, Liao, Ao, Hu, Meng, Peng, Tao and Xie.